| stavudine / Generic mfg. |
NCT00000882: Virologic and Immunologic Activity of Continued Lamivudine (3TC) vs Delavirdine (DLV) in Combination With Indinavir (IDV) and Zidovudine (ZDV) or Stavudine (d4T) in 3TC-Experienced Subjects |
|
|
| Completed | 2 | 300 | US | Indinavir sulfate, Delavirdine mesylate, Lamivudine, Stavudine, Zidovudine | National Institute of Allergy and Infectious Diseases (NIAID) | HIV Infections | 05/99 | | | |
NCT02249130: Tipranavir Dose-response Study Using a Prototype Self-emulsifying Drug Delivery System (SEDDS) Formulation in Treatment-naive HIV-1 Infected Patients Report on the Post-study Option, a Treatment of Triple Therapy With Delavirdine, ZDV and 3TC Without Tipranavir |
|
|
| Completed | 2 | 18 | US, RoW | Tipranavir (TPV), Ritonavir (RTV), Delavirdine (DLV), Zidovudine (ZDV), Lamivudine (3TC), Stavudine (d4T) | Boehringer Ingelheim | HIV Infections | 04/00 | | | |
NCT00001688: A Pilot Study of the Immunologic Reconstitution in HIV-1 Infected Children Receiving Highly Active Antiretroviral Therapy With Combination Ritonavir, Nevirapine and Stavudine |
|
|
| Completed | 2 | 25 | US | Ritonavir, Nevirapine, Stavudine | National Cancer Institute (NCI) | HIV Infection | | 11/01 | | |
NCT00002240: Study of a New Protease Inhibitor, BMS-232632, in Combination With Other Anti-HIV Drugs |
|
|
| Completed | 2 | | US, Canada | Atazanavir, Nelfinavir mesylate, Stavudine, Didanosine | Bristol-Myers Squibb | HIV Infections | 12/01 | 12/01 | | |
NCT00001122: A Study of an Adherence Plan to Help HIV-Positive Patients Take Their First Anti-HIV Medications Correctly |
|
|
| Completed | 2 | 74 | US | Nelfinavir mesylate, Efavirenz, Stavudine, Didanosine | National Institute of Allergy and Infectious Diseases (NIAID) | HIV Infections | 10/03 | | | |
NCT00002418: The Safety and Effectiveness of Didanosine Plus Stavudine Plus Nevirapine Combined With MKC-442 in HIV-Infected Patients Who Have Not Had Success With Protease Inhibitors |
|
|
| Terminated | 2 | 25 | US | Emivirine, Hydroxyurea, Nevirapine, Stavudine, Didanosine | Bristol-Myers Squibb, Boehringer Ingelheim, Triangle Pharmaceuticals | HIV Infections | | | | |
NCT00002420: The Safety and Effectiveness of Didanosine Plus Stavudine Plus Delavirdine Mesylate Plus MKC-442 in HIV-Infected Patients Who Have Not Had Success With Protease Inhibitors |
|
|
| Terminated | 2 | 25 | US | Emivirine, Hydroxyurea, Delavirdine mesylate, Stavudine, Didanosine | Bristol-Myers Squibb, Pharmacia and Upjohn, Triangle Pharmaceuticals | HIV Infections | | | | |
NCT00471614: Effects of Uridine Supplementation on Metabolic Side Effects of Stavudine and Zidovudine |
|
|
| Completed | 2 | 3 | US | NucleomaxX (contains uridine) | National Center for Complementary and Integrative Health (NCCIH) | HIV Infections, Insulin Resistance, Hyperlactatemia | 01/12 | 01/12 | | |
